The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
2020 · Nature Immunology · 785 citations
https://doi.org/10.1038/s41590-020-0769-3
A
Akihito Kawazoe
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
376
Papers
9.3K
Citations
38
h-index
69
i10-index
Akihito Kawazoe is an academic researcher from National Cancer Center Hospital East. The author has contributed to research in topics: Gastric Cancer Management and Outcomes & Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies. The author has an h-index of 38, co-authored 320 publications.
ORCID: 0000-0001-8632-3748Papers by this author
worksLactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
2022 · Cancer Cell · 778 citations
https://doi.org/10.1016/j.ccell.2022.01.001
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
2021 · Nature · 662 citations
https://doi.org/10.1038/s41586-021-04161-3
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer
2025 · New England Journal of Medicine · 130 citations
https://doi.org/10.1056/nejmoa2503701
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
2015 · BMC Cancer · 105 citations
https://doi.org/10.1186/s12885-015-1276-z
The Impact of Molecular Subtype on Efficacy of Chemotherapy and Checkpoint Inhibition in Advanced Gastric Cancer
2020 · Clinical Cancer Research · 68 citations
https://doi.org/10.1158/1078-0432.ccr-20-0075
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat